InsidersTradesSigma
Explore the full record of transactions filed by Countouriotis Athena, Chief Executive Officer. Officer active across 1 companies, notably Turning Point Therapeutics, Inc.. Aggregated, 2 reports have been logged. Total volume traded: €189k. The latest transaction was filed on 9 February 2022 — Cession. Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations
Athena Countouriotis is the President and CEO at Turning Point Therapeutics, Inc. She is responsible for the strategic direction and management of the company's operations. Athena plays a vital role in developing growth initiatives and enhancing customer experience. Her leadership and strategic vision are crucial for Turning Point's success.